JACC Basic to Translational ScienceGeneticsPeer-reviewed journal article
Systematic disruption of zebrafish fibrillin genes identifies a translational zebrafish model for Marfan syndrome
Karo De RyckeiD, Marina HorvatiD, Lisa CabooriD, Petra Vermassen, Griet De Smet, Sophie Lobbestael, Marta Santana SilvaiD, Wouter SteyaertiD, Matthias Van ImpeiD, Patrick SegersiD, Julie F A De BackeriD, Patrick Yves SipsiD
Abstract
BackgroundFibrillins are essential components of the extracellular matrix. Marfan syndrome (MFS), the most common fibrillinopathy, is characterized by severe cardiovascular complications, including cardiac valve abnormalities, myocardial dysfunction, arrhythmias, and, most commonly, thoracic aortic disease. Unfortunately, no definitive medical cure is available. ObjectivesTo establish a zebrafish model of MFS, to enhance understanding of the cardiovascular consequences of fibrillin impairment and identify novel therapeutic targets. MethodsCRISPR/Cas9 technology was used to systematically target all zebrafish fibrillin genes. The cardiovascular phenotype was investigated using fluorescent microscopy at embryonic stages and cardiac ultrasound, histology, and synchrotron X-ray imaging in adults. RNA sequencing and drug testing were performed during early development. ResultsFibrillin-2b mutant (fbn2b-/-) zebrafish had a reproducible phenotype, with a subset of embryos showing endocardial detachment leading to early mortality. Interestingly, the remaining fbn2b-/- zebrafish developed dilation of the bulbus arteriosus, a structure analogous to the aortic root in humans, and survived normally to adulthood. Adult fbn2b-/- zebrafish displayed cardiac valve abnormalities. Transcriptomic analysis of fbn2b-/-embryos suggested the involvement of extracellular matrix remodeling and immune-related pathways. Administration of nebivolol and losartan did not improve the phenotype of fbn2b-/- larvae. Zebrafish lacking fibrillin-1 and/or fibrillin-2a did not show any phenotype. ConclusionOur fbn2b-/- zebrafish model recapitulates key aspects of human cardiovascular manifestations of MFS and can therefore be considered a novel relevant animal model for MFS. Studying this model allows us to broaden the knowledge of the underlying mechanisms of the disease and discover much-needed disease-specific treatment options. CONDENSED ABSTRACTFibrillin defects lead to severe cardiovascular complications in Marfan syndrome (MFS), including aortic dilation, dissection, and rupture. To model MFS, we generated zebrafish mutants lacking various fibrillin genes. Among these mutant lines, only fibrillin-2b-deficient zebrafish exhibited cardiovascular phenotypes mimicking human disease. Multimodal imaging revealed early cardiac defects, bulbus arteriosus dilation, and valve abnormalities. Transcriptomic analysis identified altered regulation of pathways related to extracellular matrix homeostasis and immune system activation. Compound testing demonstrated the models potential for drug discovery. This zebrafish model, recapitulating key cardiovascular features of MFS, provides a valuable platform to investigate disease mechanisms and identify novel treatment strategies.
- Citations
- 3
- FWCI
- 8.01
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated luminescence and phenotypic profiling for drug discovery in a zebrafish model of Marfan syndrome
Marina Horvat, Lisa Caboor, … Patrick Yves Sips·BMC Pharmacology and ToxicologyPeer-reviewed·Oct 29, 2026
- Differential contribution of elastin and fibrillin-1 to the cardiovascular phenotype of a double heterozygous Marfan and Williams-Beuren syndrome mouse model
Isaac Rodríguez-Rovira, Lize Sels, … Gustavo Egea·Genes & DiseasesPeer-reviewed·Jun 1, 2026
- Impact of the maternal environment on cardiovascular features of the offspring in a mouse model of Marfan syndrome
Isaac Rodríguez-Rovira, Cleo Geeraerts, … Gustavo Egea·bioRxiv·Sep 10, 2025
- Targeting of MMP-13 prevents aortic aneurysm formation in Marfan mice
L.-M. A. Zimmermann, A. G. Furlan, … G. Sengle·bioRxiv·Nov 30, 2022
- Promoting translational readthrough to augment fibrillin-1 (FBN1) deposition in Marfan syndrome fibroblasts: A proof-of-concept study.
Z. Balic, D. Hubmacher·bioRxiv·Nov 23, 2022
- A Marfan-Associated FBN1 Nonsense Mutation Mouse Model Reveals Adventitial Inflammation During Aneurysm Progression
Shichao Wu, Jiawei Zhao, … Li Li·bioRxiv·Sep 23, 2025